Theralase PDT Technology Used to Treat Second Patient for Bladder Cancer
A comprehensive update from Theralase
Theralase PDT Technology Used to Treat First Patient for Bladder Cancer
The stronger fundamental case this year for gold
An up date on Theralase now beginning the phase 1b clinical trial
Roger White addresses financial questions concerning Theralase
Theralase Increases GBM Brain Cancer Survival by 925%
Theralase announces two major medical breakthroughs in its’s cancer research.
Health Canada Grants Theralase ITA Approval
Full interview with Roger White from Theralase
DID THIS DROP IN GOLD RESULT IN A BUYING OPPORTUNITY?
Theralase Increases Revenue 32% in 2H2016 Financials
2016 Sprott Natural Resource Symposium
Theralase Files ITA Application to Health Canada
New patents for Theralase
Theralase Increases Revenue 11% in Q12016 Financials
Theralase Q1 financials and an update on the ITA
Gold investment demand in the US is holding prices steady
Theralase Signs Clinical Research Agreement with University Health Network
Theralase Increases Revenue 40% in 2015 Financials

Fatal error: Call to undefined function http_response_code() in /home/kerepo5/public_html/wp-content/plugins/wp-cerber/cerber-load.php on line 5175